Sonoma Pharmaceuticals (SNOA) Financial Statements & Analysis

Sonoma Pharmaceuticals (SNOA) Income Statement

Sonoma Pharmaceuticals reported revenue of $19.53M in fiscal 2026 (fiscal year ended Mar 31, 2026), up 36.7% from $14.29M a year earlier. Sonoma Pharmaceuticals posted a net loss of $3.17M, compared with a net loss of $3.46M a year earlier. Gross margin was 38.0% and operating margin -12.6%. In the most recent quarter, Q1 fiscal 2027 (ended Jun 30, 2026), revenue was $6.41M, up 59.6% from the same quarter a year earlier.

Sonoma Pharmaceuticals Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Sonoma Pharmaceuticals, Inc. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Jun 2022	Mar 2022	Jun 2021	Mar 2021	Jun 2020	Jun 2019	Mar 2018	Mar 2017
Revenue & Gross Profit
Revenue	19.53	14.29	12.74	13.27	12.63	12.63	18.63	18.63	17.93	18.97	16.66	12.83
Cost of Revenue	12.11	8.82	7.99	8.80	8.64	8.64	12.07	12.07	9.81	10.09	9.35	7.16
Gross Profit	7.42	5.47	4.75	4.48	3.99	3.99	6.56	6.56	8.12	8.88	7.31	5.67
Operating Expenses
Research & Development	2.27	1.81	1.87	0.21	0.13	0.13	0.56	0.56	1.34	1.52	1.58	1.58
Selling, General & Administrative	7.61	7.36	7.58	8.84	9.76	9.76	9.45	9.45	14.17	18.62	19.92	17.07
Operating Expenses	9.88	9.18	9.45	9.05	9.88	9.88	10.01	10.01	15.51	20.14	21.50	18.64
Operating Income	-2.46	-3.71	-4.70	-4.57	-5.89	-5.89	-3.45	-3.45	-7.39	-11.26	-14.19	-12.97
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.02	0.00	-	0.02	0.00	0.05	0.19	0.26	0.02
Interest Expense	0.00	0.00	0.00	0.00	0.01	-0.01	0.01	-	0.02	0.03	0.04	0.00
Other Income/Expense	-0.96	0.80	-0.33	-0.61	0.47	0.47	-0.45	-0.45	3.85	-0.08	-0.09	0.04
Income
Income Before Tax	-3.42	-2.91	-5.03	-5.18	-5.42	-5.42	-3.90	-3.90	-3.54	-11.34	-14.28	-12.94
Income Tax Expense	-0.24	0.55	0.20	0.03	-0.33	0.33	0.71	-0.71	0.03	0.46	0.05	-4.27
Net Income	-3.18	-3.46	-4.84	-5.15	-5.09	-5.09	-3.95	-3.95	-3.31	-11.80	-14.33	9.27
Net Income - Continuous Operations	-3.18	-3.46	-4.84	-5.15	-5.09	-5.09	-3.95	-	-3.31	-11.80	-14.33	9.27
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-2.32	-2.77	-4.53	-4.45	-5.22	-5.70	-3.22	-3.22	-3.22	-10.85	-13.75	-12.69
EBIT	-2.46	-3.71	-4.70	-4.57	-	-5.89	-	-3.45	-	-	-	-
Depreciation & Amortization	0.14	0.14	0.18	0.13	0.19	0.19	0.23	0.23	0.31	0.45	0.49	0.25
Earnings Per Share
Basic EPS	-2.00	-3.00	-11.00	-30.00	-19.00	-38.00	-24.00	-39.00	-22.00	-128.00	-285.00	198.00
Diluted EPS	-2.00	-3.00	-11.00	-30.00	-19.00	-38.00	-24.00	-39.00	-22.00	-128.00	-285.00	198.00
Basic Shares Outstanding	1.68	1.24	0.46	0.17	0.27	0.13	0.20	0.10	0.15	0.09	0.05	0.05
Diluted Shares Outstanding	1.68	1.24	0.46	0.17	0.27	0.13	0.20	0.10	0.15	0.09	0.05	0.05

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sonoma Pharmaceuticals Financial Statements

What was Sonoma Pharmaceuticals's revenue in fiscal 2026?

Sonoma Pharmaceuticals reported revenue of $19.53M in fiscal 2026 (fiscal year ended Mar 31, 2026). That was up 36.7% from $14.29M a year earlier.

Is Sonoma Pharmaceuticals profitable?

No. Sonoma Pharmaceuticals reported a net loss of $3.17M in fiscal 2026. In fiscal 2025 it lost $3.46M.

What is Sonoma Pharmaceuticals's operating margin?

Sonoma Pharmaceuticals's operating income was −$2.46M on revenue of $19.53M in fiscal 2026, an operating margin of -12.6%, compared with -26.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition